Funding and opportunities – October 18, 2016

Susan G. Komen Inflammatory Breast Cancer Innovator Grants – CALL FOR APPLICATIONS

 

Susan G. Komen, the Milburn Foundation, and the Inflammatory Breast Cancer Research Foundation have entered into a groundbreaking partnership to provide a unique funding opportunity addressing key needs in this understudied form of breast cancer.

A major goal of this partnership is to promote innovative ideas to expand the knowledge of IBC and develop innovative new treatments.  An additional goal is to attract new investigators from diverse disciplines to apply their expertise to the IBC field.  Therefore, in addition to established IBC investigators, we encourage investigators from all fields to submit proposals for innovative IBC research, regardless of prior research experience.

These Inflammatory Breast Cancer Research Grants are intended to stimulate the exploration of new ideas and novel approaches to the field of IBC research that have significant potential to rapidly improve our understanding of IBC and TNBC.  This program will consist of two stages.  In the first stage, one year of funding will be awarded to allow investigators to establish the foundation of a robust and innovative IBC research project.  In the second stage, awardees will have the opportunity to compete for additional funding to build upon their original project. Such projects may include, but are not limited to, methods that will:

  • Develop novel diagnostic methods for rapidly identifying and diagnosing IBC
  • Refine genetic/genomic profiling of IBC
  • Discover new targeted therapies for IBC
  • Explore and further define the causes of IBC
  • Discover additional risk factors for IBC

Eligibility: Applications are open to researchers with a doctoral degree, including M.D., Ph.D., D.O., or equivalent. Applicants bay be tenure or non-tenure track faculty or a Postdoctoral Fellow (must designate a Lead Mentor with a faculty appointment at the same institution). The Applicant is not required to be currently conducting IBC research.

Funding Level: Up to $60,000 for one year.

Grant Intent: During the grant term, the PI is expected to establish the foundation for a robust and innovative IBC research project that also has the potential to impact triple negative breast cancer. Following the completion of this initial term, PIs will be invited to compete for a larger award to expand upon this project.

Closing Date:  28 November 2016.